Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122773173 | 12277317 | 3 | F | 2016 | 20160726 | 20160418 | 20160803 | PER | US-TEVA-650719USA | TEVA | 0.00 | F | Y | 0.00000 | 20160804 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122773173 | 12277317 | 1 | PS | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | C42189 | 20622 | 40 | MG | INJECTION | TIW | ||||||
| 122773173 | 12277317 | 2 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | |||||||||||
| 122773173 | 12277317 | 3 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 0 | |||||||||||
| 122773173 | 12277317 | 4 | C | FORTEO | TERIPARATIDE | 1 | Unknown | 0 | |||||||||||
| 122773173 | 12277317 | 5 | C | MELOXICAM. | MELOXICAM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122773173 | 12277317 | 1 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122773173 | 12277317 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122773173 | 12277317 | Multiple sclerosis relapse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122773173 | 12277317 | 1 | 20131017 | 0 |